Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C for Vasoplegia Syndrome After Cardiac Surgery
NCT06723626Completed
- Sponsor
- Southeast University
- Start
- Jul 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ascorbic acid in Vasoplegic Syndrome (VPS) (2 arms), sponsored by Southeast University. Primary endpoint: Duration of shock at 28 days. Started Jul 2024; status: completed.
02
Drugs
ascorbic acid
03
Conditions
Vasoplegic Syndrome (VPS)
Beyond the preview
Go deeper on NCT06723626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06723626.